Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study - PubMed (original) (raw)
Comparative Study
. 1993 Oct;16(10):1376-83.
doi: 10.2337/diacare.16.10.1376.
Affiliations
- PMID: 8269796
- DOI: 10.2337/diacare.16.10.1376
Comparative Study
Predictors of microalbuminuria in individuals with IDDM. Pittsburgh Epidemiology of Diabetes Complications Study
B A Coonrod et al. Diabetes Care. 1993 Oct.
Abstract
Objective: To examine the relationships between microalbuminuria and the development of overt diabetic nephrology, elevated blood pressure, and a more atherogenic lipid profile; and to identify risk factors for the development of microalbuminuria in individuals with IDDM. Microalbuminuria has been associated with the subsequent development of overt diabetic nephropathy in individuals with IDDM. It is associated with elevated blood pressure and a more atherogenic lipid profile, but the temporal relationship between the development of microalbuminuria and the changes in these factors is unclear.
Research design and methods: Baseline characteristics were examined in 256 individuals with IDDM who had normal albumin excretion (urinary AER < or = 20 micrograms/min in > or = 2 timed urine collections) and were re-examined 2 yr later.
Results: At follow-up, 24 had developed microalbuminuria (AER 20-200 micrograms/min in > or = 2 timed urine collections) and 1 had developed overt nephropathy (AER > 200 micrograms/min). Overall, the significant independent predictors of microalbuminuria were HbA1 (P < 0.001), low-density lipoprotein (P < 0.01), duration of IDDM (P < 0.05), and systolic blood pressure (P = 0.05). Sex-specific analyses showed HbA1, age, and baseline AER were particularly important for men; whereas, for women, the main predictors were duration of IDDM and triglycerides. Duration-specific analyses showed that HbA1 was an important predictor both for individuals with < and > 20-yr duration. Low-density lipoprotein cholesterol was more important for subjects with shorter durations; whereas triglycerides were important for those with longer durations.
Conclusions: These results suggest that glycemic control, age or duration of IDDM, disturbed lipids, and possibly elevated blood pressure all may contribute to the development of microalbuminuria; and, further, that the adverse cardiovascular risk profile seen in individuals with overt nephropathy may begin to develop even before the detection of microalbuminuria.
Similar articles
- Diabetes complications and glycemic control. The Pittsburgh Prospective Insulin-Dependent Diabetes Cohort Study Status Report after 5 yr of IDDM.
D'Antonio JA, Ellis D, Doft BH, Becker DJ, Drash AL, Kuller LH, Orchard TJ. D'Antonio JA, et al. Diabetes Care. 1989 Nov-Dec;12(10):694-70. doi: 10.2337/diacare.12.10.694. Diabetes Care. 1989. PMID: 2612304 - The changing course of diabetic nephropathy: low-density lipoprotein cholesterol and blood pressure correlate with regression of proteinuria.
Ellis D, Lloyd C, Becker DJ, Forrest KY, Orchard TJ. Ellis D, et al. Am J Kidney Dis. 1996 Jun;27(6):809-18. doi: 10.1016/s0272-6386(96)90518-1. Am J Kidney Dis. 1996. PMID: 8651245 - Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria?
Mogensen CE. Mogensen CE. Diabetes. 1990 Jul;39(7):761-7. doi: 10.2337/diab.39.7.761. Diabetes. 1990. PMID: 2191882 Review. - [Diabetic nephropathy: significance of microalbuminuria and proteinuria in Type I and Type II diabetes mellitus].
Lehmann R, Spinas GA. Lehmann R, et al. Praxis (Bern 1994). 1995 Oct 31;84(44):1265-71. Praxis (Bern 1994). 1995. PMID: 7491450 Review. German.
Cited by
- Evaluation of changes in glycemic control and diabetic complications over time and factors associated with the progression of diabetic complications in Japanese patients with juvenile-onset type 1 diabetes mellitus.
Masuda T, Katakami N, Watanabe H, Taya N, Miyashita K, Takahara M, Kato K, Kuroda A, Matsuhisa M, Shimomura I. Masuda T, et al. J Diabetes. 2024 Feb;16(2):e13486. doi: 10.1111/1753-0407.13486. Epub 2023 Oct 18. J Diabetes. 2024. PMID: 37853936 Free PMC article. - Risk factors for nephropathy in persons with type 1 diabetes: a population-based study.
Seyed Ahmadi S, Pivodic A, Svensson AM, Wedel H, Rathsman B, Nyström T, Ludvigsson J, Lind M. Seyed Ahmadi S, et al. Acta Diabetol. 2022 Jun;59(6):761-772. doi: 10.1007/s00592-022-01863-6. Epub 2022 Feb 24. Acta Diabetol. 2022. PMID: 35201418 Free PMC article. - The Association of Postprandial Triglyceride Variability with Renal Dysfunction and Microalbuminuria in Patients with Type 2 Diabetic Mellitus: A Retrospective and Observational Study.
Matsuoka-Uchiyama N, Uchida HA, Okamoto S, Onishi Y, Katayama K, Tsuchida-Nishiwaki M, Takeuchi H, Takemoto R, Hada Y, Umebayashi R, Kurooka N, Tsuji K, Eguchi J, Nakajima H, Shikata K, Wada J. Matsuoka-Uchiyama N, et al. J Diabetes Res. 2022 Jan 10;2022:3157841. doi: 10.1155/2022/3157841. eCollection 2022. J Diabetes Res. 2022. PMID: 35047644 Free PMC article. - Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy.
Srivastava SP, Zhou H, Setia O, Liu B, Kanasaki K, Koya D, Dardik A, Fernandez-Hernando C, Goodwin J. Srivastava SP, et al. Nat Commun. 2021 Apr 22;12(1):2368. doi: 10.1038/s41467-021-22617-y. Nat Commun. 2021. PMID: 33888696 Free PMC article. - Trial of Amiloride in Type 2 Diabetes with Proteinuria.
Unruh ML, Pankratz VS, Demko JE, Ray EC, Hughey RP, Kleyman TR. Unruh ML, et al. Kidney Int Rep. 2017 Sep;2(5):893-904. doi: 10.1016/j.ekir.2017.05.008. Epub 2017 May 17. Kidney Int Rep. 2017. PMID: 28890943 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous